In conclusion, to the best of our knowledge, the present study was the first to demonstrate that miR-206 suppresses glioma formation and possibly targets the downstream complementary sites of cyclinD2 to inhibit cancer cell proliferation. This evidence concerns the gene CCND2 and glioma.